@acoustics_an @demijanomeragic @ema_news the ema haven't approved valneva yet, and aside from how unsurprisingly a company making a product will say it's good, the point is that az is a pretty effective vaccine so it's not a sign of valneva being terrible if it's about as efficacious. what about the pfizer trial?